Skip to main content
. 2022 Aug 24;12(8):e062945. doi: 10.1136/bmjopen-2022-062945

Table 3.

The association of prescription of methotrexate and folic acid with COVID-19-related death in the UK Biobank

Unadjusted Model 1 Model 2
OR, (95% CI) P value OR, (95% CI) P value OR, (95% CI) P value
Neither folic acid nor methotrexate, N=363 821 1.0 1.0 1.0
Folic acid only, N=12 433 5.14 (4.23 to 6.24) <0.001 2.91 (2.38 to 3.55) <0.001 2.64 (2.15 to 3.24) <0.001
Methotrexate and folic acid, N=3952 1.47 (0.81 to 2.67) 0.21 1.26 (0.70 to 2.30) 0.44 1.07 (0.57 to 1.98) 0.84

Model 1 adjusted for age group, sex, ethnicity, Townsend deprivation index, body mass index, smoking status.

Model 2 is model 1 plus adjustment by the presence of rheumatoid arthritis, sickle cell disease, use of statins, anticonvulsants and iron supplementation.

*There were no deaths in the group of participants taking only methotrexate without folate.